Ripharma Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 10 Year, 16 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 13.09%
- Profit Growth 91.91%
- Ebitda 80.60%
- Net Worth 39.15%
- Total Assets 37.00%
About Ripharma Laboratories
Ripharma Laboratories Limited (RLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 25 March 2015 and has a history of Ten years. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Shantilal Jain, Shreepal Jain, Shrenik Jain, and Three other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100MH2015PLC262970
- Company No.
262970
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
25 Mar 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Ripharma Laboratories Limited
Explore comprehensive data for Ripharma Laboratories Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Ripharma Laboratories?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rishabh Jain  | Director | 25-Mar-2015 | Current |
| Shantilal Jain | Additional Director | 04-Feb-2025 | Current |
| Shreepal Jain | Director | 25-Mar-2015 | Current |
| Shrenik Jain | Director | 25-Mar-2015 | Current |
| Milan Jain | Director | 25-Mar-2015 | Current |
| Amit Jain | Director | 25-Mar-2015 | Current |
Financial Performance of Ripharma Laboratories.
Ripharma Laboratories Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.09% increase. The company also saw a substantial improvement in profitability, with a 91.91% increase in profit. The company's net worth Soared by an impressive increase of 39.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ripharma Laboratories?
In 2023, Ripharma Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rishabh Indotex LimitedShreepal Jain, Shrenik Jain and 1 more are mutual person
- Skyline Construtech Private Limited
Shreepal Jain, Shrenik Jain and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ripharma Laboratories?
Unlock and access historical data on people associated with Ripharma Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ripharma Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ripharma Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Ripharma Laboratories
Recent activity within the organization
- Director Appointment
Shantilal Rajmal Jain was appointed as a Additional Director was appointed as a Additional Director on 04 Feb 2025 & has been associated with this company since 2 months 5 days .
- Annual General Meeting
Ripharma Laboratories Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Ripharma Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Shreepal Champalal Jain was appointed as a Director was appointed as a Director on 25 Mar 2015 & has been associated with this company since 10 years 16 days .
- Director Appointment
Shrenik Champalal Jain was appointed as a Director was appointed as a Director on 25 Mar 2015 & has been associated with this company since 10 years 16 days .
- Director Appointment
Milan Champalal Jain was appointed as a Director was appointed as a Director on 25 Mar 2015 & has been associated with this company since 10 years 16 days .
Frequently asked questions
What is the Incorporation or founding date of Ripharma Laboratories Limited?
Ripharma Laboratories Limited was incorporated on 25 Mar 2015.
What is authorized share capital and paid-up capital of Ripharma Laboratories Limited?
The authorized share capital of Ripharma Laboratories Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Who are the current board members & directors of Ripharma Laboratories Limited?
Currently 6 directors are associated with Ripharma Laboratories Limited.
- Shantilal Rajmal Jain
- Shreepal Champalal Jain
- Shrenik Champalal Jain
- Milan Champalal Jain
- Amit Shantilal Jain
- Rishabh Shreepal Jain
What is the registered address of Ripharma Laboratories Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Ripharma Laboratories Limited is 144 Behram Mahal 534 Kalbadevi Road, Near Edward Cinema India, Mumbai, Maharashtra, 400002.
What is the corporate identification number (CIN) and company number of Ripharma Laboratories Limited?
The corporate identification number (CIN) of Ripharma Laboratories Limited is U24100MH2015PLC262970 and the company number is 262970 as per Ministry of Corporate Affairs (MCA).
What is the official website of Ripharma Laboratories Limited?
The Official website of Ripharma Laboratories Limited is https://www.ripharma.in
What has been the recent revenue trend for Ripharma Laboratories Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Ripharma Laboratories Limited has risen by 13.09%.
What change has been observed in the net worth of Ripharma Laboratories Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Ripharma Laboratories Limited has experienced an upsurge of 39.15%.
When was the last Balance Sheet of Ripharma Laboratories Limited filed with the ROC?
The most recent Balance Sheet for Ripharma Laboratories Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
CJ
Champalal JainDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India